Dear Friends, Colleagues, and Members of ESMINT,
And here we are — is it really Christmas already?
With all its promises of wonderful moments spent with family and friends, delicious little dishes, and a good glass of wine (preferably French 😊, enjoyed in moderation of course!)
No doubt with a few on-call duties and shifts thrown in… and also the traditional President’s New Year’s address!
Although still a young discipline in the history of modern medicine, Interventional Neurotherapy has become essential in improving the care of thousands of patients across Europe. The past year has once again demonstrated the strength and maturity of our field.
True to our values, we have continued to strengthen our community — a broad, committed team that drives innovation, research, and clinical excellence every day. Our collective spirit built on continuous exchange, discussion, and learning, remains our greatest asset. No neurointerventionist can deliver optimal care alone; teamwork is at the core of our success.
Education remains central to ESMINT’s mission. Through ECMINT, EXMINT, the Skills Training, Fellowships, Observerships, e-Fellowships, Online Learning, and the dissemination of best practices across Europe, we continue to train and support the next generations of practitioners.
Through EYMINT, ETMINT, and WIN, we have expanded opportunities, strengthened inclusivity, and empowered both early-career clinicians and the wider team of professionals who form the backbone of neurointerventional practice.
Our annual meeting in Marseille continues, with the same determination, to be a vibrant scientific forum — a place for debate, challenge, and shared passion for our specialty.
What’s new this year? (Follow the link or QR code below more details)
- The launch of the EastMINT project, marking an important step toward supporting underserved regions and promoting more equitable access to neurointerventional care.
- The kickoff of NeuroXChange, bringing young colleagues together and encouraging cross-centre learning and exchange.
- Completion of the final drafting phase of the consensus paper, “Clinical Trial Standards for Endovascular Devices in the Treatment of Acute Ischemic Stroke under the EU Medical Device Regulation: A Multisociety Consensus Recommendation”, by the MDR Task Force
- A strengthened research footprint through SHERPA, an EU Horizon Europe project advancing AI-assisted innovation in neurovascular interventions.
Together in 2026, I encourage all of us to continue building on this momentum. Let us strengthen the bridges we have created, deepen our collaborations, and keep inspiring the next generation of leaders in our field. Together, we will continue shaping ESMINT as a Society rooted in excellence, collaboration, free of rivalry or ego, with one single goal: to continuously improve our practice for the benefit of our patients.
Finally, none of this would be possible without the dedication of the Executive Board, the Executive Committee, our Office Team, and our invaluable ESMINT members. My sincere thanks to all of them for their work, passion, and enthusiasm. It is an honour and a privilege to serve as your President.
From the bottom of my heart, I wish you all a Happy Christmas and a wonderful New Year 2026 and express my sincere gratitude for everything we have achieved together.
Warmest wishes,
Anne Christine Januel
